BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20090405)

  • 1. The porphyrias: clinic, diagnostics, novel investigative tools and evolving molecular therapeutic strategies.
    van Serooskerken AM; Poblete-Gutiérrez P; Frank J
    Skin Pharmacol Physiol; 2010; 23(1):18-28. PubMed ID: 20090405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual porphyrias revisited.
    Poblete-Gutiérrez P; Badeloe S; Wiederholt T; Merk HF; Frank J
    Exp Dermatol; 2006 Sep; 15(9):685-91. PubMed ID: 16881965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nephrologists and porphyrias].
    Canavese C; Gabrielli D; Guida C; Cappellini MD
    G Ital Nefrol; 2002; 19(4):393-412. PubMed ID: 12369042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The molecular basis and genetics of diseases associated with disorders of heme biosynthesis].
    Fuchs O
    Cas Lek Cesk; 1996 Jan; 135(2):54-8. PubMed ID: 8616881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The acute hepatic porphyrias: current status and future challenges.
    Siegesmund M; van Tuyll van Serooskerken AM; Poblete-Gutiérrez P; Frank J
    Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):593-605. PubMed ID: 20955962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Porphyria and porphyrinology--the past fifteen years.
    McDonagh AF; Bissell DM
    Semin Liver Dis; 1998; 18(1):3-15. PubMed ID: 9516673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The porphyrias: clinical presentation, diagnosis and treatment.
    Poblete-Gutiérrez P; Wiederholt T; Merk HF; Frank J
    Eur J Dermatol; 2006; 16(3):230-40. PubMed ID: 16709484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The porphyria cutanea tarda group: their role among the enzyme defects of heme biosynthesis].
    Adrien A; Guillet G
    Sem Hop; 1984 Apr; 60(16):1148-52. PubMed ID: 6326308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme defects in hereditary porphyria.
    Civin WH; Epstein E
    Ann Clin Lab Sci; 1980; 10(5):395-401. PubMed ID: 6999973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and therapy of hepatic porphyria].
    Doss MO
    Acta Med Austriaca; 1990; 17(5):94-9. PubMed ID: 2092571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The erythropoietic porphyrias.
    Poh-Fitzpatrick MB
    Dermatol Clin; 1986 Apr; 4(2):291-6. PubMed ID: 3955899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modern diagnosis and management of the porphyrias.
    Sassa S
    Br J Haematol; 2006 Nov; 135(3):281-92. PubMed ID: 16956347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The Berzelius symposium on genetic dermatoses: cutaneous gene therapy--potential treatment of severe skin diseases].
    Vahlquist A; Rollman O
    Lakartidningen; 2002 May; 99(18):2041-5. PubMed ID: 12082782
    [No Abstract]   [Full Text] [Related]  

  • 14. Porphyria. Basic science aspects.
    Bickers DR
    Dermatol Clin; 1986 Apr; 4(2):277-90. PubMed ID: 3955898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular regulation of 5-aminolevulinate synthase. Diseases related to heme biosynthesis.
    May BK; Bhasker CR; Bawden MJ; Cox TC
    Mol Biol Med; 1990 Oct; 7(5):405-21. PubMed ID: 2095458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porphyrias.
    Scarlett YV; Brenner DA
    J Clin Gastroenterol; 1998 Oct; 27(3):192-8. PubMed ID: 9802444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Laboratory tests and therapeutic strategies for the porphyrias].
    Poblete-Gutiérrez P; Wiederholt T; Merk HF; Frank J
    Hautarzt; 2006 Jun; 57(6):493-501. PubMed ID: 16752145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Keratin diseases].
    Jensen PK; Sørensen CB; Andresen BS; Brandrup F; Veien NK; Buus SK; Gregersen N; Bolund L
    Ugeskr Laeger; 2000 Mar; 162(13):1867-72. PubMed ID: 10765692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of porphyrias in Italy: a diagnostic flow-chart.
    Martinez di Montemuros F; Di Pierro E; Patti E; Tavazzi D; Danielli MG; Biolcati G; Rocchi E; Cappellini MD
    Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):867-76. PubMed ID: 12699245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of inherited skin-blistering disorders, and therapeutic implications.
    Aumailley M; Has C; Tunggal L; Bruckner-Tuderman L
    Expert Rev Mol Med; 2006 Oct; 8(24):1-21. PubMed ID: 17040578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.